NCT05248581 Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases
| NCT ID | NCT05248581 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Rochester |
| Condition | Colorectal Cancer Metastatic |
| Study Type | OBSERVATIONAL |
| Enrollment | 25 participants |
| Start Date | 2019-08-16 |
| Primary Completion | 2027-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25 participants in total. It began in 2019-08-16 with a primary completion date of 2027-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to create a data registry to capture clinical, pathologic, and molecular data/outcomes for patients with metastatic colorectal cancer who undergo live donor liver transplantation.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 * Non-amenable to curative hepatic resection as defined by FLR \<30% * Histologically confirmed adenocarcinoma of the colon or rectum * Candidate for LDLT for colorectal liver metastasis per the University of Rochester liver transplant program Exclusion Criteria: * Not a candidate of the LDLT liver transplant protocol for treatment of colorectal liver metastasis. * Unwilling to consent
Contact & Investigator
Roberto Hernandez-Alejandro, MD
PRINCIPAL INVESTIGATOR
University of Rochester
Frequently Asked Questions
Who can join the NCT05248581 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Cancer Metastatic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05248581 currently recruiting?
Yes, NCT05248581 is actively recruiting participants. Contact the research team at roberto_hernandez@urmc.rochester.edu for enrollment information.
Where is the NCT05248581 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT05248581 clinical trial?
NCT05248581 is sponsored by University of Rochester. The principal investigator is Roberto Hernandez-Alejandro, MD at University of Rochester. The trial plans to enroll 25 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.